• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Election 2025
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Election 2025
  • Government Shutdown
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Scott Gottlieb

    Tag: Scott Gottlieb

    The Senate confirmed Scott Gottlieb to lead the Food and Drug Administration. (AP Photo/J. Scott Applewhite)
    Healthcare

    FDA frustrated with retailers over bogus kratom claims

    Robert King -
    September 11, 2018 4:13 pm
    0
    In this Wednesday, April 11, 2018 photo, an unidentified 15-year-old high school student uses a vaping device near the school's campus in Cambridge, Mass. Health and education officials across the country are raising alarms over wide underage use of e-cigarettes and other vaping products. The devices heat liquid into an inhalable vapor that's sold in sugary flavors like mango and mint — and often with the addictive drug nicotine.
    Healthcare

    Companies stop sales of kid-friendly e-cigarette liquids after FDA, FTC crackdown

    Robert King -
    August 23, 2018 7:25 pm
    0
    A pharmacist holds a package of EpiPen epinephrine auto-injectors.
    Healthcare

    FDA approves first generic competitor for EpiPen

    Robert King -
    August 16, 2018 7:19 pm
    0
    In this Sept. 27, 2017 photo, kratom capsules are displayed in Albany, N.Y. The Food and Drug Administration said in a notice Wednesday that manufacturers of supplements containing kratom should take their products off the market. (AP Photo/Mary Esch)
    Healthcare

    Salmonella scare prompts Kratom recall

    Robert King -
    August 16, 2018 2:35 pm
    0
    Vets Opioids.
    Healthcare

    FDA warns veterinarians about pet owners taking opioids meant for animals

    Kimberly Leonard -
    August 15, 2018 5:48 pm
    0
    Kratom leaves are arranged for a photograph in Pontianak, West Kalimantan, Indonesia, on Saturday, May 5, 2018. Kratom, a coffee-like evergreen that Southeast Asian farmers have long chewed to relieve pain, is one of the hottest local commodities thanks to the opioid epidemic in the U.S.
    Healthcare

    Advocates skewer FDA over ‘junk science’ blaming kratom for deaths

    Kimberly Leonard -
    August 14, 2018 6:55 pm
    0
    FDA broke monthly generic drug approval record in July
    Healthcare

    FDA broke monthly generic drug approval record in July

    Robert King -
    August 9, 2018 4:59 pm
    0
    A person smokes a Juul Labs Inc. e-cigarette in this arranged photograph taken in the Brooklyn Borough of New York, U.S., on Sunday July 8, 2018.
    Beltway Confidential

    The FDA must resist the irrational fear of vaping

    Guy Bentley -
    August 7, 2018 3:52 pm
    0
    A person smokes a Juul Labs Inc. e-cigarette in this arranged photograph taken in the Brooklyn Borough of New York, U.S., on Sunday July 8, 2018. Juul Labs, the maker of the popular e-cigarette brand that has recently come under fire from health officials over its popularity with young adults, plans to introduce a line of lower-nicotine pods. The company will begin to sell pods with a 3-percent nicotine concentration in its mint and Virginia tobacco flavors later this year, according to a statement Thursday.
    Beltway Confidential

    Trump’s FDA may finally end Obama’s war on vaping

    Paul Blair -
    August 6, 2018 7:44 pm
    0
    FDA warns against painful side effects from ‘vaginal rejuvenation’
    Healthcare

    FDA warns against painful side effects from ‘vaginal rejuvenation’

    Kimberly Leonard -
    July 30, 2018 10:11 pm
    0
    1...8910Page 9 of 10
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter